Science Explorer Back to mapMap
Discussion
Researcher · 3D-Micromac (Germany) · Germany

Klaus Brischwein

Klaus Brischwein publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Glycosylation and Glycoproteins Research.

OpenAlex
World rank
#1,126,930
of 7,710,434 ranked researchers
Rank in Germany
#55,508
of 364,343
Works
25
Citations
1.9k
Citations per work
76.5
h-index
17
i10-index 19Top 30% in Oncology
Klaus Brischwein

What does Klaus Brischwein research?

Klaus Brischwein's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (15%).

Health Sciences: 14 works · 54.2% of their workMedicine: 14 works · 54.2% of their workOncology: 7 works · 26.4% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 23.6% of their workPulmonary and Respiratory Medicine: 1 works · 4.2% of their workLife Sciences: 10 works · 40.3% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 22.2% of their workMolecular Biology: 6 works · 22.2% of their workImmunology and Microbiology: 4 works · 15.3% of their workImmunology: 4 works · 15.3% of their workAgricultural and Biological Sciences: 1 works · 2.8% of their workPlant Science: 1 works · 2.8% of their workEverything else: 1 works · 5.5% of their workTHEIR WORKKlaus Brischwein25works
Life Sciences40%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1454.2%
    1. Biochemistry, Genetics and Molecular Biology622.2%
    2. Immunology and Microbiology415.3%
    3. Agricultural and Biological Sciences12.8%
  3. Everything else15.5%
  1. 1Oncology26% of their works
  2. 2Radiology, Nuclear Medicine and Imaging24% of their works
  3. 3Molecular Biology22% of their works
  4. 4Immunology15% of their works
  5. 5Pulmonary and Respiratory Medicine4% of their works
  6. 6Plant Science3% of their works

Research topics

Which keywords describe Klaus Brischwein's research?

The keywords of their largest research topics: Glycosylation, Fc Receptors, Therapeutic Antibodies, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Cancer and Glycans.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glycosylation232 topics
  2. Fc Receptors171 topic
  3. Therapeutic Antibodies171 topic
  4. Cancer Immunotherapy152 topics
  5. CAR T Cells121 topic
  6. Chimeric Antigen Receptor121 topic
  7. Cancer82 topics
  8. Glycans61 topic
  9. Immune System61 topic
  10. Dendritic Cells31 topic
  11. Immunity31 topic
  12. Immunotoxin31 topic
  13. NK Cell Recognition31 topic
  14. Natural Killer Cells31 topic
  15. Ricin Poisoning31 topic
  16. DNA21 topic
  17. DNA Damage21 topic
  18. Repair21 topic
  19. Topoisomerases21 topic

Where does Klaus Brischwein work?

Klaus Brischwein's main affiliation in the publication record is 3D-Micromac (Germany), Germany.

How many publications and citations does Klaus Brischwein have?

OpenAlex counts 25 works and 1,912 citations for Klaus Brischwein, an h-index of 17, ranking #1,126,930 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Klaus Brischwein. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.